These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18345706)

  • 1. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Woodside DG; Vanderslice P
    BioDrugs; 2008; 22(2):85-100. PubMed ID: 18345706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD.
    Vanderslice P; Biediger RJ; Woodside DG; Berens KL; Holland GW; Dixon RA
    Pulm Pharmacol Ther; 2004; 17(1):1-10. PubMed ID: 14643165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectin antagonists : therapeutic potential in asthma and COPD.
    Romano SJ
    Treat Respir Med; 2005; 4(2):85-94. PubMed ID: 15813660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting selectins for the treatment of respiratory diseases.
    Romano SJ; Slee DH
    Curr Opin Investig Drugs; 2001 Jul; 2(7):907-13. PubMed ID: 11757789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease.
    Mitroulis I; Alexaki VI; Kourtzelis I; Ziogas A; Hajishengallis G; Chavakis T
    Pharmacol Ther; 2015 Mar; 147():123-135. PubMed ID: 25448040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of synthetic pan-selectin antagonists: a new treatment strategy for chronic inflammation in asthma.
    Aydt E; Wolff G
    Pathobiology; 2002-2003; 70(5):297-301. PubMed ID: 12771513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-selectin therapy for the treatment of inflammatory diseases.
    Rossi B; Constantin G
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):85-93. PubMed ID: 18691137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting leukocyte integrins in human diseases.
    Yonekawa K; Harlan JM
    J Leukoc Biol; 2005 Feb; 77(2):129-40. PubMed ID: 15548573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 4 integrin antagonists.
    Jackson DY
    Curr Pharm Des; 2002; 8(14):1229-53. PubMed ID: 12052218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
    Wright DB; Meurs H; Dekkers BG
    Trends Pharmacol Sci; 2014 Nov; 35(11):567-74. PubMed ID: 25441775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte integrins and their ligand interactions.
    Hyun YM; Lefort CT; Kim M
    Immunol Res; 2009 Dec; 45(2-3):195-208. PubMed ID: 19184539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.
    Watz H; Bock D; Meyer M; Schierhorn K; Vollhardt K; Woischwill C; Pedersen F; Kirsten A; Beeh KM; Meyer-Sabellek W; Magnussen H; Beier J
    Pulm Pharmacol Ther; 2013 Apr; 26(2):265-70. PubMed ID: 23257347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration.
    Radi ZA; Kehrli ME; Ackermann MR
    J Vet Intern Med; 2001; 15(6):516-29. PubMed ID: 11817056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation.
    Robinson LA; Tu L; Steeber DA; Preis O; Platt JL; Tedder TF
    J Immunol; 1998 Dec; 161(12):6931-8. PubMed ID: 9862727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction.
    Rychly J; Nebe B
    Curr Pharm Des; 2006; 12(29):3799-806. PubMed ID: 17073678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
    Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C
    Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs.
    Hilden TJ; Nurmi SM; Fagerholm SC; Gahmberg CG
    Ann Med; 2006; 38(7):503-11. PubMed ID: 17101541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin antagonists.
    Curley GP; Blum H; Humphries MJ
    Cell Mol Life Sci; 1999 Oct; 56(5-6):427-41. PubMed ID: 11212296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E- and P-selectin: differences, similarities and implications for the design of P-selectin antagonists.
    Binder FP; Ernst B
    Chimia (Aarau); 2011; 65(4):210-3. PubMed ID: 21678763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.